About ParaMet

ParaMet (A systematic analysis of parasite metabolism – from metabolism to intervention) is a Marie Curie Initial Training Network funded by the European Commission and currently involves 12 scientific and industrial partners from 6 European countries. The project is coordinated by Professor Sylke Müller at the University of Glasgow, UK with the administrative support of Gillian Murray and her team.

ParaMet will train a new generation of European scientists (Experienced and Early Stage Researchers) in the requisites of preclinical drug discovery, combining academic excellence in innovation with industrial rigor and thus providing inter-disciplinary training from an academic and industrial perspective.

Early Stage Researchers & Experienced Researchers

1st Annual Meeting, Arcachon               (ERs, ESRs and PIs)                                                                                  12 PhD Scholarships and 2 Postdoctoral positions are funded by the Marie Curie Initial Training Network to study parasite metabolism and to contribute to drug discovery against neglected tropical diseases and malaria

 

 

Location of ParaMet Collaborators

Please click on one of the markers on the map of Europe to see where our collaborators are based, what projects they are working on and to be able to click through to their individual profiles.

Marco Biddau

Marco Biddau

University of Glasgow

Dissecting the link between cytosolic and mitochondrial glucose metabolism in Plasmodium falciparum

Fernando  Fernandez-Cortes

Fernando Fernandez-Cortes

University of Glasgow

Systems analysis of the role of protein kinases in trypanosome metabolic regulation

Julie Kovarova

Julie Kovarova

University of Glasgow

The metabolic consequences of perturbation to the pentose phosphate pathway in trypanosomes and Leishmania

Sabine Fraschka

Sabine Fraschka

Radboud University of Nijmegen

Discovering the epigenetic-metabolic interface in Plasmodium

Francis Isidore Totañes

Francis Isidore Totañes

University of Leeds

Modelling apicomplexan metabolic and transcriptional regulatory networks

Marion Wargnies

Marion Wargnies

Université de Bordeaux (CNRS)

Identification of new metabolic pathways in trypanosomatids

Daniela Begalo

Daniela Begalo

University of Heidelberg

Drug target identification in Trypanosoma brucei using an over-expression library

Maria Fatarová

Maria Fatarová

Institut National de la Receherche Agronomique (INRA)

Metabolic consequences of gene knockout in Trypanosomes

Sanu Shameer

Sanu Shameer

Institut National de la Receherche Agronomique (INRA)

Genome-Scale Reconstruction and study of Trypanosoma metabolism from a Systems Biology perspective

Ewelina Guca

Ewelina Guca

Université Montpellier II

Characterisation of unexplored key steps of phospholipid metabolism in Plasmodium and their potential use as pharmacological targets

Maria Valente

Maria Valente

Instituto de Parasitologia y Biomedicina Lopez-Neyra

Exploring pyrimidine metabolism in Trypanosoma brucei and identification of natural products with antitrypanosomal activity

Frederick Annang

Frederick Annang

Fundación MEDINA

Identification of natural products against malaria and kinetoplastid diseases

Dr Tina Weber

Dr Tina Weber

MSD Animal Health Innovation GmbH (INTERVET)

Cyclin-dependent kinases of Eimeria as drug targets

Dr Diana Tegazzini

Dr Diana Tegazzini

GlaxoSmithKline (GSK)

Establishment of the target metabolic pathways of new antitrypanosomal

Affiliated  Member

Affiliated Member

Medivir

Medivir is a pharmaceutical company dedicated to discovery and development of potential therapeutic agents

map of europe
Plasmodium
Eimeria
Trypanosoma brucei gambiense
Leishmania
Trypanosoma cruzi

Events

Previous Meetings
10 December 2013, 16.46 Previous Meetings
Training Events & Meeting Dates
04 January 2013, 08.59 Training Events & Meeting Dates

Publications

Recent Publications
11 December 2013, 15.22 Recent Publications